Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Espinoza Octavio. Officer active across 1 company, notably Ligand Pharmaceuticals INC. In total, 39 reports have been published. Split: 1 buy · 7 sells. Total volume traded: €9.8m. Activity tracked since 9 November 2022. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Espinoza Octavio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1417 títulos@ 80,72 US$4.5% de su flujoCommon StockSEC:0002001011-24-000084:0
25 de 39 declaraciones
About Espinoza Octavio
Espinoza Octavio is a declarant with 33 filings in total. Among the recent filings tracked, they span 2022-11-10 to 2026-07-06, the modal transaction nature is Levée d'options, and the cumulative amounts are EUR 92559 of buys and EUR 1682363 of sells. Ligand Pharmaceuticals INC, XNAS, is the only listed company, where the stated role is Chief Financial Officer.